IGF2BP3 and hepatocellular carcinoma: Our results demonstrated that hsa_circ_0026134 influenced the malignant behavior of HCC cells via the miR-127-5p/IGF2BP3 and miR-127-5p/TRIM25 regulatory networks, suggesting that hsa_circ_0026134 is a potential therapeutic target.